- Home
- LPX vs MMED Comparison
LPX vs MMED Comparison
Compare LPX & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPX | MMED |
|---|---|---|
| Founded | 1973 | 1983 |
| Country | United States | United States |
| Employees | N/A | 2800 |
| Industry | Forest Products | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 5.5B |
| IPO Year | 1994 | 2025 |
Fundamental Metrics
Financial Performance| Metric | LPX | MMED |
|---|---|---|
| Price | $64.38 | $19.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 13 |
| Target Price | ★ $92.07 | $24.92 |
| AVG Volume (30 Days) | 917.4K | ★ 2.3M |
| Earning Date | 11-04-2026 | 11-10-2026 |
| Dividend Yield | ★ 1.86% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.76 | N/A |
| Revenue | $2,708,000,000.00 | ★ $3,102,000,000.00 |
| Revenue This Year | N/A | $10.82 |
| Revenue Next Year | $11.87 | $8.28 |
| P/E Ratio | $87.01 | ★ N/A |
| Revenue Growth | N/A | ★ 14.25 |
| 52 Week Low | $64.49 | $10.65 |
| 52 Week High | $100.34 | $24.43 |
Technical Indicators
Market Signals| Indicator | LPX | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 34.83 | 40.11 |
| Support Level | N/A | $10.68 |
| Resistance Level | $76.95 | $20.88 |
| Average True Range (ATR) | 1.92 | 0.81 |
| MACD | 0.01 | -0.38 |
| Stochastic Oscillator | 3.35 | 6.74 |
Price Performance
Historical ComparisonAbout LPX Louisiana-Pacific Corporation
Louisiana-Pacific Corp is an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The Siding business of the company serves different markets with a broad product portfolio of engineered wood siding, trim, soffit, and fascia. The Company operates through three operating segments: Siding, OSB, and LP South America (LPSA). The company generates majority of its revenue from siding segment.
About MMED MiniMed Group Inc. Common Stock
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.